Study to Identify the Reduction of Exacerbations Resulting in Hospital Admission in Patients With COPD.

identification of the reduction of exacerbations resulting in hospital admission in COPD patients after the use of the Breath Detect telemedicine platform.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COPD Exacerbation

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CS Entrevías

Madrid, 28053, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

COPD diagnosed in GOLD II state or higher

Exclusion criteria

Can´t read and talk in spanish

Treatment and study plan

Breath Detect Platform

Diagnostic Test

Use of the Breath Detect platform for respiratory health monitoring.

Primary outcomes

Number of hospital admissions due to exacerbations

Time frame: 24 weeks

Sponsors and collaborators

Lead sponsor

Universidad Autonoma de Madrid

Other

Registry information

Official study title

Identification of the Reduction of Exacerbations Resulting in Hospital Admission in COPD Patients After the Use of the Breath Detect Telemedicine Platform.

Acronym: BDS

Important dates

Study start: 2022
Primary completion: 2023
Study completion: 2023
First posted: Jun 30, 2022
Registry last updated: Dec 6, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed